Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: J Cancer Surviv. 2010 Mar;4(1):33–44. doi: 10.1007/s11764-009-0105-2

Table 2.

Demographics and treatment-related factors by SF-36 physical (PCS) and mental (MCS) component scores at 6 months post-transplant

N=106a SF-36 PCS at 6 months
SF-36 MCS at 6 months
Characteristic PCS >40
34(32%)
N(%)
PCS ≤40
72(68%)
N(%)
P value MCS >40
80(75%)
N(%)
MCS ≤40
26(25%)
N(%)
P value
Age at transplant, years
 <35 12(35) 16(22) 0.65 22(28) 6(23) 0.49
 35–49 14(41) 40(56) 42(53) 12(46)
 ≥50 8(24) 16(22) 16(20) 8(31)
Female 19(56) 43(60) 0.99 47(59) 15(58) 0.90
Education ≥4 years college 20(59) 31(43) 0.25 33(41) 18(69) 0.03
Married 21(59) 51(71) 0.23 53(66) 18(69) 0.86
Pre-transplant risk group
 Low 19(56) 26(36) 0.12 34(43) 11(42) 0.65
 Moderate 12(35) 29(40) 30(38) 11(42)
 High 3(9) 17(24) 16(20) 4(15)
Total body irradiation 21(62) 35(49) 0.42 44(55) 12(46) 0.37
Chronic graft-vs-host disease (GVHD)b 18(53) 48(67) 0.22 48(60) 18(69) 0.51
a

Sample is comprised of the 106 HCT patients who had not returned to work and had not died or relapsed by 6 months post-HCT. An imputation prediction model generated SF-36 scores for 17 cases with missing PCS and MCS scores

b

Report of clinical extensive chronic GVHD onset at any point during the first 5 years after HCT